APA (7th ed.) Citation

Mirzazadeh, H., Ghaeminia, Y., Mohamad Niaei, A., Kamran, M., Razeghian Jahromi, L., & Moshfeghinia, R. (2025). Memantine augmentation of escitalopram in treatment of executive function among patients with obsessive-compulsive disorder (OCD): A double-blind placebo-controlled randomized clinical trial. BMC Psychiatry, 25(1), 1. https://doi.org/10.1186/s12888-025-06856-7

Chicago Style (17th ed.) Citation

Mirzazadeh, Hasan, Younes Ghaeminia, Amin Mohamad Niaei, Mohammadsadegh Kamran, Leila Razeghian Jahromi, and Reza Moshfeghinia. "Memantine Augmentation of Escitalopram in Treatment of Executive Function Among Patients with Obsessive-compulsive Disorder (OCD): A Double-blind Placebo-controlled Randomized Clinical Trial." BMC Psychiatry 25, no. 1 (2025): 1. https://doi.org/10.1186/s12888-025-06856-7.

MLA (9th ed.) Citation

Mirzazadeh, Hasan, et al. "Memantine Augmentation of Escitalopram in Treatment of Executive Function Among Patients with Obsessive-compulsive Disorder (OCD): A Double-blind Placebo-controlled Randomized Clinical Trial." BMC Psychiatry, vol. 25, no. 1, 2025, p. 1, https://doi.org/10.1186/s12888-025-06856-7.